CA2841093A1 - Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof - Google Patents

Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof Download PDF

Info

Publication number
CA2841093A1
CA2841093A1 CA2841093A CA2841093A CA2841093A1 CA 2841093 A1 CA2841093 A1 CA 2841093A1 CA 2841093 A CA2841093 A CA 2841093A CA 2841093 A CA2841093 A CA 2841093A CA 2841093 A1 CA2841093 A1 CA 2841093A1
Authority
CA
Canada
Prior art keywords
beta
antibody
peptide
peptides
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2841093A
Other languages
English (en)
French (fr)
Inventor
Marc Hubert Mercken
Marianne BORGERS
Marc Maria Pierre Pelagie Vandermeeren
Bianca Julia J. Van Broeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of CA2841093A1 publication Critical patent/CA2841093A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA2841093A 2011-07-15 2012-07-06 Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof Abandoned CA2841093A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11174224 2011-07-15
EP11174224.3 2011-07-15
PCT/EP2012/063213 WO2013010812A1 (en) 2011-07-15 2012-07-06 Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof

Publications (1)

Publication Number Publication Date
CA2841093A1 true CA2841093A1 (en) 2013-01-24

Family

ID=44936656

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2841093A Abandoned CA2841093A1 (en) 2011-07-15 2012-07-06 Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof

Country Status (8)

Country Link
US (1) US8911731B2 (enExample)
EP (1) EP2731968A1 (enExample)
JP (1) JP2014520825A (enExample)
CN (1) CN103687876A (enExample)
AU (1) AU2012286021A1 (enExample)
CA (1) CA2841093A1 (enExample)
EA (1) EA201490286A1 (enExample)
WO (1) WO2013010812A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004029629A1 (en) * 2002-09-27 2004-04-08 Janssen Pharmaceutica N.V. N-11 truncated amyloid-beta nomoclonal antibodies, compositions, methods and uses
CN114478762B (zh) * 2022-02-15 2024-06-04 武汉天德生物科技有限公司 一种β-淀粉样多肽1-42单克隆抗体、ELISA试剂盒及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173127B2 (en) * 1997-04-09 2012-05-08 Intellect Neurosciences, Inc. Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
UA91683C2 (ru) * 2004-07-30 2010-08-25 Ринат Нейросаенз Корп. Антитела, направленные против бета-амилоидного пептида, и способы их применения
UY29504A1 (es) * 2005-04-29 2006-10-31 Rinat Neuroscience Corp Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
CN101223185A (zh) * 2005-05-17 2008-07-16 萨托里医药公司 用于治疗神经变性障碍的化合物
EA021047B1 (ru) 2009-07-15 2015-03-31 Янссен Фармасьютикалз, Инк. Замещенные производные триазола и имидазола в качестве модуляторов гамма-секретазы

Also Published As

Publication number Publication date
CN103687876A (zh) 2014-03-26
US20140154715A1 (en) 2014-06-05
EA201490286A1 (ru) 2014-04-30
JP2014520825A (ja) 2014-08-25
US8911731B2 (en) 2014-12-16
AU2012286021A1 (en) 2014-01-16
EP2731968A1 (en) 2014-05-21
WO2013010812A1 (en) 2013-01-24

Similar Documents

Publication Publication Date Title
CA2498058C (en) N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses
JP4790013B2 (ja) β−アミロイドの血中分解速度測定によるアルツハイマー病の検定に用いられる方法及び診断試薬
US9347954B2 (en) Antibody capable of binding to specific region of periostin, and method of measuring periostin using the same
JP2017512056A (ja) ヒト・タウに結合する抗体および該抗体を使用してヒト・タウを定量するためのアッセイ
JP2017534595A (ja) ヒトｐ５３の直線状エピトープに結合する抗体及びその診断的応用
US8911731B2 (en) Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof
KR101338517B1 (ko) 인간 간-카르복실에스터라제 １을 특이적으로 인식하는 단일클론 항체, 상기 항체를 생산하는 하이브리도마 세포주 및 이의 용도
EP0938678B1 (en) Method and kit for the diagnosis of troponin i
WO2003104812A2 (en) ASSAY FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE BASED ON THE DETERMINATION OF THE RATIO OF hAβ42:hAβ40
JP2001048900A (ja) 抗体及びこれを使用した測定法
HK1081647B (en) N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses
JP2007127472A (ja) グリシル化ガストリン（ｇｌｙｃｉｎｅ−ｅｘｔｅｎｄｅｄｇａｓｔｒｉｎ）の分析方法
HK1126797A (en) N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses
JP2005145837A (ja) アルツハイマー病の診断方法
JP2006069908A (ja) シロイヌナズナのセントロメアに特異的に存在するＡｔＭｉｓ１２タンパク質検出用抗体
JP2558956C (enExample)

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20170622

FZDE Discontinued

Effective date: 20190708